Compared to the group with no treatment, we observed ~60% tumor regression on day 21 when treated with 10 × 106 FRα‐CAR+T cells (p < 0.01) and ~35% by 3 × 106 FRα‐CAR+T cells (p < 0.01). This evidence concerns the gene FOLR1 and neoplasm.